Q/C Technologies Delays Annual 10-K Filing Briefly

Q/C Technologies ( (QCLS) ) has released a notification of late filing.

Q/C Technologies, Inc. has filed a Form 12b-25, notifying investors that it will delay its Form 10-K (Yearly Report) for the fiscal year ended December 31, 2025. The company, formerly known as TNF Pharmaceuticals, says the filing extension applies solely to its annual report.

Management explains that the delay stems from the need for additional time to complete and finalize the financial statements required in the Form 10-K (Yearly Report). It notes that filing on the original deadline would have required unreasonable effort and expense, but does not cite any auditor change, control failure, or external investigation.

The company states that it expects to submit the Form 10-K (Yearly Report) on or before the fifteenth calendar day after the original SEC due date. For investors, this means the delay is currently framed as a short, procedural extension rather than an open-ended reporting issue.

Q/C Technologies indicates that all other required SEC periodic reports over the last 12 months have been filed on time. It also does not anticipate any significant change in results of operations versus the prior fiscal year in the earnings statements that will be included in the delayed Form 10-K (Yearly Report), though actual results remain subject to completion of the audit and normal closing adjustments.

The notification is signed on behalf of the company by Executive Chairman Joshua Silverman on March 31, 2026, underscoring management’s responsibility for compliance. Q/C Technologies signals that it is working to finalize its numbers and bring its annual reporting current within the short extension window allowed under SEC rules.

More about Q/C Technologies

Average Trading Volume: 1,164,078

Technical Sentiment Signal: Strong Sell

Current Market Cap: $25.45M

See more data about QCLS stock on TipRanks’ Stock Analysis page.